Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer
Countries citing papers authored by Róbert Hermann
Since
Specialization
Citations
This map shows the geographic impact of Róbert Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Hermann more than expected).
This network shows the impact of papers produced by Róbert Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Hermann. The network helps show where Róbert Hermann may publish in the future.
Co-authorship network of co-authors of Róbert Hermann
This figure shows the co-authorship network connecting the top 25 collaborators of Róbert Hermann.
A scholar is included among the top collaborators of Róbert Hermann based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Róbert Hermann. Róbert Hermann is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Olbrich, Martin, et al.. (2001). Morpholine ring oxidation of AWD 131-138, a novel anxiolytic and anticonvulsant, is catalysed by CYP1A1/2.. Drug Metabolism Reviews. 33. 89.2 indexed citations
Schneider, Edith, G Niebch, Róbert Hermann, Peter Ruus, & Harald O. Borbe. (1995). Absolute bioavailability of flupirtine capsules drops and suppositories in man. European Journal of Clinical Pharmacology. 49. 161.1 indexed citations
8.
Hermann, Róbert. (1977). Toda lattices, cosymplectic manifolds, Bäcklund transformations, and kinks. CERN Document Server (European Organization for Nuclear Research).5 indexed citations
9.
Hermann, Róbert. (1976). The geometry of non-linear differential equations, Bäcklund transformations, and solitons. CERN Document Server (European Organization for Nuclear Research).9 indexed citations
10.
Hermann, Róbert. (1976). Geometric structure of systems-control theory and physics. CERN Document Server (European Organization for Nuclear Research).4 indexed citations
11.
Hermann, Róbert. (1974). Linear systems theory and introductory algebraic geometry. CERN Document Server (European Organization for Nuclear Research).6 indexed citations
12.
Hermann, Róbert. (1974). Spinors, Clifford, and Cayley algebras. CERN Document Server (European Organization for Nuclear Research).11 indexed citations
13.
Hermann, Róbert. (1969). Fourier analysis on groups and partial wave analysis. CERN Document Server (European Organization for Nuclear Research).19 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.